Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Tuesday, February 4, 2025.
NovaBay Pharmaceuticals, Inc. (AMEX:NBY)
Weak Uptrend (+65) - NBY is showing signs of weakening momentum to the upside. Monitor NBY as it may be in the beginning stages of a reversal.
Is it time to buy, sell, or avoid NBY?
MarketClub looks at technical strength and momentum to determine if the timing is right for NBY.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for NBY
The long-term trend has been UP since May 17th, 2024 at 0.1796
The intermediate-term trend has been UP since Dec 31st, 2024 at 0.6000
The short-term trend has been DOWN since Jan 24th, 2025 at 0.6850
Smart Scan Analysis for NBY
Based on our trend formula, NBY is rated as a +65 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 0.625100 | 0.669300 | 0.615200 | 0.636899 | -0.027401 |
| Prev. Close | Volume | Bid | Ask | Time |
| 0.664300 | 65058 | 2025-02-04 15:19:07 |
| Year High | 4.2 | Year High Date | 2018-01-02 |
| Year Low | 0.9659 | Year Low Date | 2018-11-06 |
| 52wk High | 9.079 | 52wk High Date | 2024-05-17 |
| 52wk Low | 0.3611 | 52wk Low Date | 2024-08-09 |
| Year End Close | 1.13 | Average Volume | 501,293 |
| Shares Outstanding | 4,886 | Short Interest | 1,099,006 |
| % Institutional | 16.8 | Market Cap | 9M |
| Assets | 3,877,000M | Liabilities | 2,805,000M |
| P/E Ratio | -0.02990000 | Beta | 0.99 |
| Volatility | 80.83 |